Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-10-30
2007-10-30
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S275000, C544S320000, C544S324000, C544S325000, C544S331000
Reexamination Certificate
active
10384787
ABSTRACT:
This invention relates to 2-heteroaryl-pyrimidine derivatives of general formula I or Ifas inhibitors of the cyclin-dependent kinases, their production as well as their use as medications for treating various diseases.
REFERENCES:
patent: 6197779 (2001-03-01), Andries et al.
patent: WO 99/02162 (1999-01-01), None
patent: WO 0039101 (2000-07-01), None
patent: WO 01/14375 (2001-03-01), None
patent: WO 0164654 (2001-09-01), None
patent: WO 204429 (2002-01-01), None
Cecil Textbook of Medicine, edited by Bennet, J.C., and Plum F., 20th edition,vol. 1, 1004-1010, 1996.
Malumbres et al., Trends in Biochemical Sciences, 30(11), 630-641, 2005.
Lolli et al., Cell Cycle 4 :4, 572-577, 2005.
Sherr et al., Genes & Development 18, 2699-2711, 2004.
Fischer Cell Cycle 3:6, 742-746, 2004.
Ernst Alexander
Jautelat Rolf
Kruger Martin
Lücking Ulrich
Prien Olaf
Balasubramanian Venkataraman
Millen White Zelano & Branigan P.C.
Schering AG
LandOfFree
CDK-inhibitory 2-heteroaryl-pyrimidines, their production... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with CDK-inhibitory 2-heteroaryl-pyrimidines, their production..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CDK-inhibitory 2-heteroaryl-pyrimidines, their production... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3862937